MODERN APPROACHES TO THE TREATMENT OF RHEUMATOID ARTHRITIS
Ключевые слова:
Rheumatoid arthritis, autoimmune disease, biological therapy, targeted therapyАннотация
Rheumatoid arthritis is a chronic autoimmune inflammatory disease that primarily affects the joints and may lead to progressive disability if not treated appropriately. Recent advances in immunology and molecular medicine have significantly improved the understanding of disease mechanisms and contributed to the development of innovative therapeutic approaches. This article reviews modern strategies for the treatment of rheumatoid arthritis, including conventional disease-modifying antirheumatic drugs, biological therapies, and targeted synthetic agents. Particular attention is given to the importance of early diagnosis, the treat-to-target concept, individualized treatment plans, and continuous monitoring of disease activity. The findings indicate that modern therapeutic interventions effectively reduce inflammation, prevent joint destruction, improve physical function, and enhance the quality of life of patients. The study emphasizes the necessity of comprehensive and patient-centered management in achieving long-term remission and favorable clinical outcomes.
##plugins.themes.default.displayStats.downloads##
Библиографические ссылки
1. Khodjiyeva, Z. B., & Ahmedov, A. A. (2022). Modern diagnostic and treatment approaches in rheumatic diseases. Tashkent: Medical Publishing House.
2. Ismoilov, B. R., & Ergasheva, D. M. (2023). The role of immunomodulatory therapy in autoimmune diseases. Journal of Medicine and Practice, 5(2), 33–39.
3. Smolen, J. S., Aletaha, D., McInnes, I. B. (2023). Rheumatoid arthritis. The Lancet, 401(10386), 1357–1374
4. Fraenkel, L., Bathon, J. M., England, B. R., St. Clair, E. W., Arayssi, T., Carandang, K., et al. (2021). 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care & Research, 73(7), 924–939.
5. Smolen, J. S., Landewé, R. B. M., Bergstra, S. A., Kerschbaumer, A., Sepriano, A., Aletaha, D., et al. (2023). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Annals of the Rheumatic Diseases, 82(1), 3–18.
6. McInnes, I. B., & Schett, G. (2023). Pathogenetic insights from the treatment of rheumatoid arthritis. The Lancet, 401(10386), 1321–1333.
7. Firestein, G. S., Budd, R. C., Gabriel, S. E., McInnes, I. B., O'Dell, J. R. (2024). Kelley's Textbook of Rheumatology (11th ed.). Philadelphia: Elsevier.
8. Singh, J. A., Saag, K. G., Bridges, S. L., Akl, E. A., Bannuru, R. R., Sullivan, M. C., et al. (2022). American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis & Rheumatology, 74(1), 1–16.
9. Scott, D. L., Wolfe, F., Huizinga, T. W. J. (2022). Rheumatoid arthritis. The New England Journal of Medicine, 387(4), 340–352.



















